nodes	percent_of_prediction	percent_of_DWPC	metapath
Phensuximide—CYP2C19—prostate cancer	0.473	1	CbGaD
Phensuximide—CYP2C19—Bicalutamide—prostate cancer	0.111	0.288	CbGbCtD
Phensuximide—CYP2C19—Nilutamide—prostate cancer	0.111	0.288	CbGbCtD
Phensuximide—CYP2C19—Flutamide—prostate cancer	0.0922	0.239	CbGbCtD
Phensuximide—CYP2C19—Estradiol—prostate cancer	0.0383	0.0992	CbGbCtD
Phensuximide—CYP2C19—Prednisone—prostate cancer	0.0329	0.0853	CbGbCtD
Phensuximide—CYP2C19—urine—prostate cancer	0.00347	0.236	CbGeAlD
Phensuximide—Menadione—F9—prostate cancer	0.00296	0.287	CrCbGaD
Phensuximide—CACNA1H—prostate gland—prostate cancer	0.00262	0.178	CbGeAlD
Phensuximide—CACNA1I—testis—prostate cancer	0.00257	0.175	CbGeAlD
Phensuximide—CACNA1H—seminal vesicle—prostate cancer	0.00222	0.15	CbGeAlD
Phensuximide—CACNA1I—lymph node—prostate cancer	0.00187	0.127	CbGeAlD
Phensuximide—CACNA1H—testis—prostate cancer	0.00115	0.0783	CbGeAlD
Phensuximide—Menadione—AOX1—prostate cancer	0.001	0.097	CrCbGaD
Phensuximide—CACNA1H—lymph node—prostate cancer	0.000837	0.0568	CbGeAlD
Phensuximide—Menadione—BGLAP—prostate cancer	0.000793	0.0767	CrCbGaD
Phensuximide—Menadione—NQO1—prostate cancer	0.000536	0.0518	CrCbGaD
Phensuximide—Antipyrine—CYP2C18—prostate cancer	0.000483	0.0467	CrCbGaD
Phensuximide—Menadione—MTHFR—prostate cancer	0.000334	0.0323	CrCbGaD
Phensuximide—Antipyrine—CYP2A6—prostate cancer	0.000308	0.0298	CrCbGaD
Phensuximide—Menadione—CYP2A6—prostate cancer	0.000286	0.0277	CrCbGaD
Phensuximide—Clobazam—CYP2C18—prostate cancer	0.00027	0.0261	CrCbGaD
Phensuximide—Tranylcypromine—CYP2A6—prostate cancer	0.000259	0.025	CrCbGaD
Phensuximide—Methsuximide—CYP2C19—prostate cancer	0.000252	0.0244	CrCbGaD
Phensuximide—Antipyrine—CYP2E1—prostate cancer	0.000219	0.0211	CrCbGaD
Phensuximide—Antipyrine—CYP2C19—prostate cancer	0.000217	0.0209	CrCbGaD
Phensuximide—Menadione—CYP2E1—prostate cancer	0.000203	0.0197	CrCbGaD
Phensuximide—Menadione—CYP1A1—prostate cancer	0.000201	0.0194	CrCbGaD
Phensuximide—Tranylcypromine—CYP2E1—prostate cancer	0.000184	0.0178	CrCbGaD
Phensuximide—Tranylcypromine—CYP2C19—prostate cancer	0.000182	0.0176	CrCbGaD
Phensuximide—Ethotoin—CYP2C19—prostate cancer	0.000181	0.0175	CrCbGaD
Phensuximide—Primidone—CYP2C19—prostate cancer	0.000168	0.0162	CrCbGaD
Phensuximide—Diazepam—CYP2C18—prostate cancer	0.000158	0.0152	CrCbGaD
Phensuximide—Methylphenobarbital—CYP2C19—prostate cancer	0.000157	0.0152	CrCbGaD
Phensuximide—Antipyrine—CYP3A4—prostate cancer	0.000138	0.0133	CrCbGaD
Phensuximide—Antipyrine—PTGS2—prostate cancer	0.000135	0.013	CrCbGaD
Phensuximide—Clobazam—CYP2C19—prostate cancer	0.000121	0.0117	CrCbGaD
Phensuximide—Tranylcypromine—CYP3A4—prostate cancer	0.000116	0.0112	CrCbGaD
Phensuximide—Primidone—CYP3A4—prostate cancer	0.000107	0.0103	CrCbGaD
Phensuximide—Diazepam—CYP3A5—prostate cancer	0.000104	0.01	CrCbGaD
Phensuximide—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A1—prostate cancer	9.4e-05	0.000808	CbGpPWpGaD
Phensuximide—CYP2C19—Metapathway biotransformation—SULT2A1—prostate cancer	9.38e-05	0.000806	CbGpPWpGaD
Phensuximide—CACNA1G—Developmental Biology—LEP—prostate cancer	9.29e-05	0.000798	CbGpPWpGaD
Phensuximide—CACNA1H—Axon guidance—JAK2—prostate cancer	9.18e-05	0.000789	CbGpPWpGaD
Phensuximide—CACNA1I—Developmental Biology—JAK2—prostate cancer	9.17e-05	0.000788	CbGpPWpGaD
Phensuximide—CACNA1G—Axon guidance—ERBB2—prostate cancer	9.12e-05	0.000784	CbGpPWpGaD
Phensuximide—CACNA1G—Developmental Biology—KDR—prostate cancer	9.1e-05	0.000782	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism of lipids and lipoproteins—GRHL1—prostate cancer	9.02e-05	0.000775	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism of lipids and lipoproteins—CBR1—prostate cancer	9.02e-05	0.000775	CbGpPWpGaD
Phensuximide—CACNA1H—Developmental Biology—LEP—prostate cancer	9e-05	0.000773	CbGpPWpGaD
Phensuximide—CYP2C19—Metapathway biotransformation—GPX3—prostate cancer	8.94e-05	0.000769	CbGpPWpGaD
Phensuximide—CACNA1H—Axon guidance—ERBB2—prostate cancer	8.83e-05	0.000759	CbGpPWpGaD
Phensuximide—CACNA1I—Developmental Biology—ERBB2—prostate cancer	8.83e-05	0.000759	CbGpPWpGaD
Phensuximide—CACNA1H—Developmental Biology—KDR—prostate cancer	8.81e-05	0.000757	CbGpPWpGaD
Phensuximide—CACNA1I—Axon guidance—EGFR—prostate cancer	8.58e-05	0.000737	CbGpPWpGaD
Phensuximide—CYP2C19—Biological oxidations—HPGDS—prostate cancer	8.53e-05	0.000733	CbGpPWpGaD
Phensuximide—CYP2C19—Biological oxidations—GSTT1—prostate cancer	8.27e-05	0.000711	CbGpPWpGaD
Phensuximide—CYP2C19—Biological oxidations—CYP2A6—prostate cancer	8.17e-05	0.000702	CbGpPWpGaD
Phensuximide—CACNA1I—Axon guidance—KRAS—prostate cancer	8.1e-05	0.000696	CbGpPWpGaD
Phensuximide—CACNA1G—Developmental Biology—GSK3B—prostate cancer	8.04e-05	0.000691	CbGpPWpGaD
Phensuximide—CYP2C19—Arachidonic acid metabolism—PTGS2—prostate cancer	7.98e-05	0.000686	CbGpPWpGaD
Phensuximide—CACNA1G—Developmental Biology—INS—prostate cancer	7.93e-05	0.000682	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism of lipids and lipoproteins—MBTPS1—prostate cancer	7.88e-05	0.000678	CbGpPWpGaD
Phensuximide—CYP2C19—Metapathway biotransformation—AKR1C3—prostate cancer	7.84e-05	0.000674	CbGpPWpGaD
Phensuximide—CYP2C19—Biological oxidations—CYP17A1—prostate cancer	7.83e-05	0.000673	CbGpPWpGaD
Phensuximide—CACNA1G—Axon guidance—MMP9—prostate cancer	7.82e-05	0.000672	CbGpPWpGaD
Phensuximide—CACNA1H—Developmental Biology—GSK3B—prostate cancer	7.79e-05	0.000669	CbGpPWpGaD
Phensuximide—CACNA1G—Developmental Biology—CREBBP—prostate cancer	7.77e-05	0.000668	CbGpPWpGaD
Phensuximide—CACNA1I—Developmental Biology—CTNNB1—prostate cancer	7.72e-05	0.000664	CbGpPWpGaD
Phensuximide—CYP2C19—Metapathway biotransformation—CYP17A1—prostate cancer	7.72e-05	0.000663	CbGpPWpGaD
Phensuximide—Clobazam—CYP3A4—prostate cancer	7.69e-05	0.00744	CrCbGaD
Phensuximide—CACNA1H—Developmental Biology—INS—prostate cancer	7.68e-05	0.00066	CbGpPWpGaD
Phensuximide—CACNA1H—Axon guidance—MMP9—prostate cancer	7.58e-05	0.000651	CbGpPWpGaD
Phensuximide—CACNA1I—Developmental Biology—MMP9—prostate cancer	7.57e-05	0.000651	CbGpPWpGaD
Phensuximide—CACNA1H—Developmental Biology—CREBBP—prostate cancer	7.53e-05	0.000647	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism of lipids and lipoproteins—AMACR—prostate cancer	7.47e-05	0.000642	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism of lipids and lipoproteins—DEGS1—prostate cancer	7.47e-05	0.000642	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism of lipids and lipoproteins—SRD5A2—prostate cancer	7.47e-05	0.000642	CbGpPWpGaD
Phensuximide—CYP2C19—Biological oxidations—NCOA2—prostate cancer	7.46e-05	0.000641	CbGpPWpGaD
Phensuximide—CACNA1G—Developmental Biology—MMP2—prostate cancer	7.43e-05	0.000638	CbGpPWpGaD
Phensuximide—CACNA1G—Developmental Biology—MAP2K1—prostate cancer	7.42e-05	0.000637	CbGpPWpGaD
Phensuximide—CACNA1G—Axon guidance—SRC—prostate cancer	7.21e-05	0.00062	CbGpPWpGaD
Phensuximide—CACNA1H—Developmental Biology—MMP2—prostate cancer	7.19e-05	0.000618	CbGpPWpGaD
Phensuximide—CACNA1H—Developmental Biology—MAP2K1—prostate cancer	7.18e-05	0.000617	CbGpPWpGaD
Phensuximide—CACNA1I—Developmental Biology—EP300—prostate cancer	7.18e-05	0.000617	CbGpPWpGaD
Phensuximide—Diazepam—CYP2E1—prostate cancer	7.13e-05	0.0069	CrCbGaD
Phensuximide—CYP2C19—Metabolism of lipids and lipoproteins—HSD17B1—prostate cancer	7.13e-05	0.000613	CbGpPWpGaD
Phensuximide—Diazepam—CYP2C19—prostate cancer	7.06e-05	0.00683	CrCbGaD
Phensuximide—CACNA1G—Developmental Biology—FGF2—prostate cancer	7.06e-05	0.000606	CbGpPWpGaD
Phensuximide—CACNA1G—Axon guidance—VEGFA—prostate cancer	7.02e-05	0.000604	CbGpPWpGaD
Phensuximide—CACNA1H—Axon guidance—SRC—prostate cancer	6.99e-05	0.0006	CbGpPWpGaD
Phensuximide—CACNA1I—Developmental Biology—SRC—prostate cancer	6.98e-05	0.0006	CbGpPWpGaD
Phensuximide—CYP2C19—Biological oxidations—CYP2E1—prostate cancer	6.95e-05	0.000597	CbGpPWpGaD
Phensuximide—CYP2C19—Metapathway biotransformation—CYP2E1—prostate cancer	6.85e-05	0.000589	CbGpPWpGaD
Phensuximide—CACNA1H—Developmental Biology—FGF2—prostate cancer	6.83e-05	0.000587	CbGpPWpGaD
Phensuximide—CACNA1H—Axon guidance—VEGFA—prostate cancer	6.8e-05	0.000585	CbGpPWpGaD
Phensuximide—CACNA1I—Developmental Biology—VEGFA—prostate cancer	6.8e-05	0.000584	CbGpPWpGaD
Phensuximide—CACNA1G—Developmental Biology—JAK2—prostate cancer	6.76e-05	0.000581	CbGpPWpGaD
Phensuximide—CACNA1I—Developmental Biology—STAT3—prostate cancer	6.73e-05	0.000579	CbGpPWpGaD
Phensuximide—CYP2C19—Biological oxidations—CYP3A4—prostate cancer	6.7e-05	0.000576	CbGpPWpGaD
Phensuximide—CYP2C19—Metapathway biotransformation—CYP3A4—prostate cancer	6.61e-05	0.000568	CbGpPWpGaD
Phensuximide—CACNA1I—Axon guidance—IL6—prostate cancer	6.59e-05	0.000566	CbGpPWpGaD
Phensuximide—CYP2C19—Biological oxidations—CYP1B1—prostate cancer	6.59e-05	0.000566	CbGpPWpGaD
Phensuximide—CACNA1H—Developmental Biology—JAK2—prostate cancer	6.55e-05	0.000563	CbGpPWpGaD
Phensuximide—CACNA1G—Developmental Biology—ERBB2—prostate cancer	6.51e-05	0.000559	CbGpPWpGaD
Phensuximide—CYP2C19—Metapathway biotransformation—CYP1B1—prostate cancer	6.5e-05	0.000558	CbGpPWpGaD
Phensuximide—CYP2C19—Biological oxidations—GGT1—prostate cancer	6.38e-05	0.000548	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism of lipids and lipoproteins—HPGD—prostate cancer	6.36e-05	0.000546	CbGpPWpGaD
Phensuximide—CACNA1G—Axon guidance—EGFR—prostate cancer	6.32e-05	0.000543	CbGpPWpGaD
Phensuximide—CACNA1H—Developmental Biology—ERBB2—prostate cancer	6.3e-05	0.000542	CbGpPWpGaD
Phensuximide—CYP2C19—Biological oxidations—NCOA1—prostate cancer	6.29e-05	0.00054	CbGpPWpGaD
Phensuximide—CACNA1I—Developmental Biology—TGFB1—prostate cancer	6.24e-05	0.000536	CbGpPWpGaD
Phensuximide—CYP2C19—Biological oxidations—CYP19A1—prostate cancer	6.19e-05	0.000532	CbGpPWpGaD
Phensuximide—CACNA1H—Axon guidance—EGFR—prostate cancer	6.12e-05	0.000526	CbGpPWpGaD
Phensuximide—CACNA1I—Developmental Biology—EGFR—prostate cancer	6.12e-05	0.000526	CbGpPWpGaD
Phensuximide—CYP2C19—Metapathway biotransformation—CYP19A1—prostate cancer	6.11e-05	0.000525	CbGpPWpGaD
Phensuximide—CYP2C19—Biological oxidations—RXRA—prostate cancer	5.98e-05	0.000514	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism of lipids and lipoproteins—TNFRSF21—prostate cancer	5.98e-05	0.000514	CbGpPWpGaD
Phensuximide—CACNA1G—Axon guidance—KRAS—prostate cancer	5.97e-05	0.000513	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism of lipids and lipoproteins—CYP7B1—prostate cancer	5.81e-05	0.0005	CbGpPWpGaD
Phensuximide—CACNA1H—Axon guidance—KRAS—prostate cancer	5.78e-05	0.000497	CbGpPWpGaD
Phensuximide—CACNA1I—Developmental Biology—KRAS—prostate cancer	5.78e-05	0.000497	CbGpPWpGaD
Phensuximide—CYP2C19—Biological oxidations—COMT—prostate cancer	5.76e-05	0.000495	CbGpPWpGaD
Phensuximide—CYP2C19—Biological oxidations—GSTP1—prostate cancer	5.73e-05	0.000493	CbGpPWpGaD
Phensuximide—CACNA1G—Developmental Biology—CTNNB1—prostate cancer	5.69e-05	0.000489	CbGpPWpGaD
Phensuximide—CYP2C19—Metapathway biotransformation—COMT—prostate cancer	5.68e-05	0.000488	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism of lipids and lipoproteins—SRD5A1—prostate cancer	5.66e-05	0.000487	CbGpPWpGaD
Phensuximide—CYP2C19—Metapathway biotransformation—GSTP1—prostate cancer	5.65e-05	0.000486	CbGpPWpGaD
Phensuximide—CACNA1G—Developmental Biology—MMP9—prostate cancer	5.58e-05	0.00048	CbGpPWpGaD
Phensuximide—CACNA1H—Developmental Biology—CTNNB1—prostate cancer	5.51e-05	0.000474	CbGpPWpGaD
Phensuximide—CACNA1H—Developmental Biology—MMP9—prostate cancer	5.41e-05	0.000465	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism of lipids and lipoproteins—ACSL4—prostate cancer	5.4e-05	0.000464	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism of lipids and lipoproteins—HSD17B3—prostate cancer	5.4e-05	0.000464	CbGpPWpGaD
Phensuximide—CACNA1G—Developmental Biology—EP300—prostate cancer	5.29e-05	0.000455	CbGpPWpGaD
Phensuximide—CYP2C19—Biological oxidations—GSTM1—prostate cancer	5.27e-05	0.000453	CbGpPWpGaD
Phensuximide—CYP2C19—Metapathway biotransformation—GSTM1—prostate cancer	5.19e-05	0.000446	CbGpPWpGaD
Phensuximide—CACNA1G—Developmental Biology—SRC—prostate cancer	5.15e-05	0.000442	CbGpPWpGaD
Phensuximide—CACNA1H—Developmental Biology—EP300—prostate cancer	5.13e-05	0.000441	CbGpPWpGaD
Phensuximide—CACNA1G—Developmental Biology—VEGFA—prostate cancer	5.01e-05	0.000431	CbGpPWpGaD
Phensuximide—CYP2C19—Biological oxidations—CYP1A1—prostate cancer	4.99e-05	0.000429	CbGpPWpGaD
Phensuximide—CACNA1H—Developmental Biology—SRC—prostate cancer	4.98e-05	0.000428	CbGpPWpGaD
Phensuximide—CACNA1G—Developmental Biology—STAT3—prostate cancer	4.96e-05	0.000427	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—HAO1—prostate cancer	4.93e-05	0.000423	CbGpPWpGaD
Phensuximide—CYP2C19—Metapathway biotransformation—CYP1A1—prostate cancer	4.92e-05	0.000423	CbGpPWpGaD
Phensuximide—CACNA1G—Axon guidance—IL6—prostate cancer	4.86e-05	0.000418	CbGpPWpGaD
Phensuximide—CACNA1H—Developmental Biology—VEGFA—prostate cancer	4.86e-05	0.000417	CbGpPWpGaD
Phensuximide—CACNA1H—Developmental Biology—STAT3—prostate cancer	4.81e-05	0.000413	CbGpPWpGaD
Phensuximide—CACNA1H—Axon guidance—IL6—prostate cancer	4.71e-05	0.000404	CbGpPWpGaD
Phensuximide—CACNA1I—Developmental Biology—IL6—prostate cancer	4.7e-05	0.000404	CbGpPWpGaD
Phensuximide—CACNA1G—Developmental Biology—TGFB1—prostate cancer	4.6e-05	0.000395	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism of lipids and lipoproteins—HSD3B1—prostate cancer	4.59e-05	0.000395	CbGpPWpGaD
Phensuximide—CACNA1G—Developmental Biology—EGFR—prostate cancer	4.51e-05	0.000388	CbGpPWpGaD
Phensuximide—Diazepam—CYP3A4—prostate cancer	4.49e-05	0.00434	CrCbGaD
Phensuximide—CACNA1H—Developmental Biology—TGFB1—prostate cancer	4.46e-05	0.000383	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism of lipids and lipoproteins—TBXAS1—prostate cancer	4.41e-05	0.000379	CbGpPWpGaD
Phensuximide—CACNA1H—Developmental Biology—EGFR—prostate cancer	4.37e-05	0.000375	CbGpPWpGaD
Phensuximide—CACNA1I—Developmental Biology—AKT1—prostate cancer	4.34e-05	0.000373	CbGpPWpGaD
Phensuximide—CACNA1G—Developmental Biology—KRAS—prostate cancer	4.26e-05	0.000366	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism of lipids and lipoproteins—ABCG5—prostate cancer	4.24e-05	0.000364	CbGpPWpGaD
Phensuximide—CACNA1H—Developmental Biology—KRAS—prostate cancer	4.13e-05	0.000355	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism of lipids and lipoproteins—HSD3B2—prostate cancer	4.1e-05	0.000352	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—ADI1—prostate cancer	4.02e-05	0.000345	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—CSAD—prostate cancer	4.02e-05	0.000345	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—TST—prostate cancer	4.02e-05	0.000345	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—PSAT1—prostate cancer	4.02e-05	0.000345	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—GRHL1—prostate cancer	4.02e-05	0.000345	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—CBR1—prostate cancer	4.02e-05	0.000345	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism of lipids and lipoproteins—LRP2—prostate cancer	3.93e-05	0.000337	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism of lipids and lipoproteins—P4HB—prostate cancer	3.85e-05	0.000331	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—UGT2B15—prostate cancer	3.73e-05	0.000321	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—GRHPR—prostate cancer	3.73e-05	0.000321	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—UGT2B17—prostate cancer	3.73e-05	0.000321	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—CKMT2—prostate cancer	3.73e-05	0.000321	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism of lipids and lipoproteins—SULT2A1—prostate cancer	3.65e-05	0.000314	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism of lipids and lipoproteins—MED12—prostate cancer	3.59e-05	0.000309	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—SULT2B1—prostate cancer	3.51e-05	0.000302	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—AOX1—prostate cancer	3.51e-05	0.000302	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—NAGLU—prostate cancer	3.51e-05	0.000302	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—GSTM3—prostate cancer	3.51e-05	0.000302	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—PGAM2—prostate cancer	3.51e-05	0.000302	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—MBTPS1—prostate cancer	3.51e-05	0.000302	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—RFK—prostate cancer	3.51e-05	0.000302	CbGpPWpGaD
Phensuximide—CACNA1G—Developmental Biology—IL6—prostate cancer	3.47e-05	0.000298	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism of lipids and lipoproteins—NCOA3—prostate cancer	3.43e-05	0.000295	CbGpPWpGaD
Phensuximide—CACNA1H—Developmental Biology—IL6—prostate cancer	3.36e-05	0.000289	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—CYP3A43—prostate cancer	3.33e-05	0.000286	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—AMACR—prostate cancer	3.33e-05	0.000286	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—SRD5A2—prostate cancer	3.33e-05	0.000286	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—DEGS1—prostate cancer	3.33e-05	0.000286	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—NAT1—prostate cancer	3.33e-05	0.000286	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism of lipids and lipoproteins—HPGDS—prostate cancer	3.27e-05	0.000281	CbGpPWpGaD
Phensuximide—CACNA1G—Developmental Biology—AKT1—prostate cancer	3.2e-05	0.000275	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—HSD17B1—prostate cancer	3.18e-05	0.000273	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism of lipids and lipoproteins—ACHE—prostate cancer	3.18e-05	0.000273	CbGpPWpGaD
Phensuximide—CACNA1H—Developmental Biology—AKT1—prostate cancer	3.1e-05	0.000266	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C3—prostate cancer	3.05e-05	0.000262	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism of lipids and lipoproteins—PRKACB—prostate cancer	3.04e-05	0.000261	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism of lipids and lipoproteins—CYP17A1—prostate cancer	3.01e-05	0.000258	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism of lipids and lipoproteins—NCOA2—prostate cancer	2.86e-05	0.000246	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—B4GALT4—prostate cancer	2.83e-05	0.000243	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—HPGD—prostate cancer	2.83e-05	0.000243	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—TNFRSF21—prostate cancer	2.66e-05	0.000229	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—CYP7B1—prostate cancer	2.59e-05	0.000222	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—MTAP—prostate cancer	2.59e-05	0.000222	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—prostate cancer	2.53e-05	0.000217	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—SULT1E1—prostate cancer	2.52e-05	0.000217	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—SRD5A1—prostate cancer	2.52e-05	0.000217	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism of lipids and lipoproteins—GGT1—prostate cancer	2.45e-05	0.000211	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism of lipids and lipoproteins—NCOA1—prostate cancer	2.41e-05	0.000207	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—ACSL4—prostate cancer	2.41e-05	0.000207	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—HSD17B3—prostate cancer	2.41e-05	0.000207	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—prostate cancer	2.38e-05	0.000204	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—PHGDH—prostate cancer	2.31e-05	0.000198	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—UMPS—prostate cancer	2.31e-05	0.000198	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—ARG2—prostate cancer	2.31e-05	0.000198	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism of lipids and lipoproteins—RXRA—prostate cancer	2.3e-05	0.000197	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—LDHB—prostate cancer	2.26e-05	0.000194	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—CYP3A5—prostate cancer	2.22e-05	0.000191	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—PDHA1—prostate cancer	2.14e-05	0.000184	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—UCP3—prostate cancer	2.14e-05	0.000184	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—GSTA3—prostate cancer	2.14e-05	0.000184	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—TCN2—prostate cancer	2.14e-05	0.000184	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—SLC22A3—prostate cancer	2.05e-05	0.000176	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—HSD3B1—prostate cancer	2.05e-05	0.000176	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism of lipids and lipoproteins—LPL—prostate cancer	1.99e-05	0.000171	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—TBXAS1—prostate cancer	1.96e-05	0.000169	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—GSTA4—prostate cancer	1.96e-05	0.000169	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—prostate cancer	1.92e-05	0.000165	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—GSTA2—prostate cancer	1.91e-05	0.000164	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—SULT1A1—prostate cancer	1.89e-05	0.000162	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—ABCG5—prostate cancer	1.89e-05	0.000162	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—GSTA1—prostate cancer	1.84e-05	0.000159	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—GSTO1—prostate cancer	1.82e-05	0.000157	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—HSD3B2—prostate cancer	1.82e-05	0.000157	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—NAT2—prostate cancer	1.82e-05	0.000157	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	1.75e-05	0.000151	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—PLCB2—prostate cancer	1.75e-05	0.00015	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—LRP2—prostate cancer	1.75e-05	0.00015	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—CYP2C18—prostate cancer	1.75e-05	0.00015	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—P4HB—prostate cancer	1.71e-05	0.000147	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—SLC22A1—prostate cancer	1.67e-05	0.000143	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	1.65e-05	0.000142	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—SULT2A1—prostate cancer	1.63e-05	0.00014	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—MED12—prostate cancer	1.6e-05	0.000137	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—GNG5—prostate cancer	1.59e-05	0.000136	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—NCOA3—prostate cancer	1.53e-05	0.000131	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	1.5e-05	0.000129	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—HPGDS—prostate cancer	1.46e-05	0.000125	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—ACHE—prostate cancer	1.41e-05	0.000122	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—GSTT1—prostate cancer	1.41e-05	0.000122	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—CYP2A6—prostate cancer	1.4e-05	0.00012	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	1.39e-05	0.00012	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—AKR1C3—prostate cancer	1.36e-05	0.000117	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—PRKACB—prostate cancer	1.35e-05	0.000116	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—CYP17A1—prostate cancer	1.34e-05	0.000115	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	1.32e-05	0.000113	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—NCOA2—prostate cancer	1.28e-05	0.00011	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—SLC5A5—prostate cancer	1.22e-05	0.000105	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—CYP2E1—prostate cancer	1.19e-05	0.000102	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—NQO1—prostate cancer	1.18e-05	0.000101	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—TH—prostate cancer	1.16e-05	9.95e-05	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	1.15e-05	9.89e-05	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—CYP3A4—prostate cancer	1.15e-05	9.85e-05	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	1.14e-05	9.8e-05	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—CYP1B1—prostate cancer	1.13e-05	9.68e-05	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—GGT1—prostate cancer	1.09e-05	9.38e-05	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—NCOA1—prostate cancer	1.07e-05	9.24e-05	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—CYP19A1—prostate cancer	1.06e-05	9.1e-05	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—RXRA—prostate cancer	1.02e-05	8.79e-05	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	9.94e-06	8.55e-05	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—COMT—prostate cancer	9.85e-06	8.46e-05	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—GSTP1—prostate cancer	9.8e-06	8.42e-05	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—ITPR1—prostate cancer	9.65e-06	8.29e-05	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism of lipids and lipoproteins—EP300—prostate cancer	9.48e-06	8.15e-05	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—TYMS—prostate cancer	9.11e-06	7.83e-05	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—GSTM1—prostate cancer	9.01e-06	7.74e-05	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—LPL—prostate cancer	8.84e-06	7.6e-05	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—CYP1A1—prostate cancer	8.54e-06	7.34e-05	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—ERCC2—prostate cancer	8.47e-06	7.28e-05	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—MTHFR—prostate cancer	7.96e-06	6.84e-05	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—PPARA—prostate cancer	7.81e-06	6.71e-05	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—CAV1—prostate cancer	7.34e-06	6.31e-05	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	7.02e-06	6.03e-05	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—PIK3CG—prostate cancer	6.69e-06	5.75e-05	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—INS—prostate cancer	6.33e-06	5.44e-05	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—CREBBP—prostate cancer	6.2e-06	5.33e-05	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—PIK3CD—prostate cancer	5.88e-06	5.05e-05	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—NOS3—prostate cancer	5.55e-06	4.77e-05	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—PIK3CB—prostate cancer	5.13e-06	4.4e-05	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—PTGS2—prostate cancer	5.08e-06	4.36e-05	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—PTEN—prostate cancer	4.43e-06	3.81e-05	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—EP300—prostate cancer	4.22e-06	3.63e-05	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—PIK3CA—prostate cancer	3.12e-06	2.69e-05	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—AKT1—prostate cancer	2.55e-06	2.19e-05	CbGpPWpGaD
